- Home
- RDFN vs CLDX Comparison
RDFN vs CLDX Comparison
Compare RDFN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDFN
- CLDX
- Stock Information
- Founded
- RDFN 2002
- CLDX N/A
- Country
- RDFN United States
- CLDX United States
- Employees
- RDFN N/A
- CLDX N/A
- Industry
- RDFN Real Estate
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RDFN Finance
- CLDX Health Care
- Exchange
- RDFN Nasdaq
- CLDX Nasdaq
- Market Cap
- RDFN 1.2B
- CLDX 1.3B
- IPO Year
- RDFN 2017
- CLDX 2008
- Fundamental
- Price
- RDFN $9.78
- CLDX $19.77
- Analyst Decision
- RDFN Hold
- CLDX Buy
- Analyst Count
- RDFN 11
- CLDX 9
- Target Price
- RDFN $10.85
- CLDX $50.00
- AVG Volume (30 Days)
- RDFN 7.4M
- CLDX 931.3K
- Earning Date
- RDFN 05-06-2025
- CLDX 05-08-2025
- Dividend Yield
- RDFN N/A
- CLDX N/A
- EPS Growth
- RDFN N/A
- CLDX N/A
- EPS
- RDFN N/A
- CLDX N/A
- Revenue
- RDFN $1,038,527,000.00
- CLDX $7,559,000.00
- Revenue This Year
- RDFN $0.10
- CLDX N/A
- Revenue Next Year
- RDFN $2.78
- CLDX N/A
- P/E Ratio
- RDFN N/A
- CLDX N/A
- Revenue Growth
- RDFN 5.11
- CLDX 24.49
- 52 Week Low
- RDFN $5.49
- CLDX $14.40
- 52 Week High
- RDFN $15.29
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- RDFN 48.53
- CLDX 52.51
- Support Level
- RDFN $9.41
- CLDX $18.55
- Resistance Level
- RDFN $10.41
- CLDX $20.67
- Average True Range (ATR)
- RDFN 0.47
- CLDX 1.16
- MACD
- RDFN -0.02
- CLDX -0.05
- Stochastic Oscillator
- RDFN 33.50
- CLDX 62.03
About RDFN Redfin Corporation
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments real estate services, rentals, mortgage, title, and monetization. The company generates the majority of its revenue from Real estate services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.